6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease

Gastroenterology
Marla C DubinskyEric A Vasiliauskas

Abstract

Approximately 40% of inflammatory bowel disease (IBD) patients fail to benefit from 6-mercaptopurine (6-MP)/azathioprine (AZA). Recent reports suggest 6-thioguanine nucleotide (6-TGN) levels (>235) independently correlate with remission. An inverse correlation between 6-TGN and thiopurine methyltransferase (TPMT) has been described. The objectives of this study were to determine whether dose escalation optimizes both 6-TGN levels and efficacy in patients failing therapy because of subtherapeutic 6-TGN levels and its effect on TPMT. Therapeutic efficacy and adverse events were recorded at baseline and upon reevaluation after dose escalation in 51 IBD patients. 6-MP metabolite levels and TPMT activity were recorded blinded to clinical information. Fourteen of 51 failing 6-MP/AZA at baseline achieved remission upon dose escalation, which coincided with significant rises in 6-TGN levels. Despite increased 6-MP/AZA doses, 37 continued to fail therapy at follow-up. Dose escalation resulted in minor changes in 6-TGN, yet a significant increase in 6-methylmercaptopurine ribonucleotides (6-MMPR) (P < or = 0.01) and 6-MMPR:6-TGN ratio (P < 0.001). 6-MMPR rises were associated with dose-dependent hepatotoxicity in 12 patients (24%). TPMT ...Continue Reading

Citations

Sep 28, 2002·Journal of Pediatric Gastroenterology and Nutrition·Carolina RumboBenjamin L Shneider
Mar 8, 2003·Alimentary Pharmacology & Therapeutics·K R HerrlingerE F Stange
Dec 19, 2003·Expert Opinion on Pharmacotherapy·Alan Ronald BremnerRobert Mark Beattie
Feb 28, 2004·American Journal of Pharmacogenomics : Genomics-related Research in Drug Development and Clinical Practice·Hèctor Corominas, Montserrat Baiget
May 29, 2004·Therapeutic Drug Monitoring·Luc J J DerijksPiet M Hooymans
Jun 12, 2004·Alimentary Pharmacology & Therapeutics·K R HerrlingerM Schwab
Feb 16, 2005·Alimentary Pharmacology & Therapeutics·F N Aberra, G R Lichtenstein
Jul 29, 2005·Journal of Gastroenterology and Hepatology·Richard B Gearry, Murray L Barclay
Jun 21, 2005·Alimentary Pharmacology & Therapeutics·C A Siegel, B E Sands
May 24, 2006·Molecular Pharmacology·Birgitta I EklundBengt Mannervik
Nov 25, 2005·Clinical Chemistry·Monica ArenasAnthony M Marinaki
Sep 7, 2006·Journal of Pediatric Gastroenterology and Nutrition·Sanjoy Banerjee, Warren P Bishop
Sep 4, 2007·The American Journal of Gastroenterology·Nanne K H de BoerAdriaan A van Bodegraven
Jun 5, 2007·Inflammatory Bowel Diseases·Laurence J Egan
May 9, 2008·Expert Opinion on Drug Safety·Albert J Czaja
Jul 29, 2008·Alimentary Pharmacology & Therapeutics·L Peyrin-BirouletJ-P Bronowicki
Sep 2, 2008·Expert Opinion on Drug Safety·Rupert Wl LeongMiles P Sparrow
May 25, 2010·Journal of Gastroenterology and Hepatology·Richard B GearryMiles P Sparrow
Jun 15, 2010·Nucleosides, Nucleotides & Nucleic Acids·S VikingssonC Peterson
Oct 1, 2010·Journal of Gastroenterology and Hepatology·Peter R Gibson, Richard B Gearry
Jun 10, 2010·Journal of Pediatric Gastroenterology and Nutrition·David DunkinTamir Miloh
Oct 16, 2010·Inflammatory Bowel Diseases·Jean-Baptiste ChevauxMiles P Sparrow
Nov 26, 2010·Inflammatory Bowel Diseases·Stephen B HanauerBruce E Sands
Feb 9, 2012·Nature Reviews. Gastroenterology & Hepatology·Michael Camilleri
Apr 5, 2012·Gastroenterology Research and Practice·Victor UkoKadakkal Radhakrishnan
Mar 6, 2012·Journal of Crohn's & Colitis·Melissa A SmithJeremy D Sanderson
Dec 21, 2012·International Journal of Clinical Practice·M SmithJ Sanderson
Jan 5, 2013·Journal of Pediatric Gastroenterology and Nutrition·Keith BenkovUNKNOWN NASPGHAN Committee on Inflammatory Bowel Disease
Jul 3, 2013·Clinical Chemistry·Laurent ChouchanaMarie-Anne Loriot
Nov 19, 2013·Alimentary Pharmacology & Therapeutics·T DassopoulosS B Hanauer
Jun 12, 2014·Journal of Pediatric Gastroenterology and Nutrition·U KopylovE G Seidman
Apr 29, 2015·Expert Review of Gastroenterology & Hepatology·Rimma Goldberg, Peter M Irving
Dec 23, 2014·Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·E A HullahJ D Sanderson
Oct 28, 2016·Clinical and Translational Gastroenterology·Darcy Q HoltGregory T Moore
Jul 29, 2016·Therapeutic Drug Monitoring·Margien L SeinenAdriaan A van Bodegraven
Jan 29, 2017·Clinical Rheumatology·Aurélie ChapdelaineMaxime Doré
Mar 10, 2018·Inflammatory Bowel Diseases·Erik Munnig-SchmidtMurray L Barclay

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.